New Antibody for Targeting Cancer
Author Information
Author(s): Tsunoda S, Ohizumi I, Matsui J, Koizumi K, Wakai Y, Makimoto H, Tsutsumi Y, Utoguchi N, Taniguchi K, Saito H, Harada N, Ohsugi Y, Mayumi T
Primary Institution: Department of Biopharmaceutics, School of Pharmaceutical Sciences, Osaka University
Hypothesis
Can the TES-23 antibody specifically target tumor vascular endothelium in various cancer types?
Conclusion
The TES-23 antibody shows high specificity for tumor vascular endothelium and can effectively deliver drugs to various types of cancer.
Supporting Evidence
- TES-23 accumulated significantly in tumor tissues compared to normal tissues.
- The antibody's binding was confirmed through immunostaining of human cancer tissue.
- The immunoconjugate showed marked regression of tumors in animal models.
Takeaway
Scientists found a special antibody that can find and attack cancer cells, helping to deliver medicine right where it's needed.
Methodology
The study assessed the tissue distribution of the TES-23 antibody in tumor-bearing animals and tested its efficacy as a drug carrier.
Participant Demographics
The study involved various tumor-bearing animals including mice and rats.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website